Table 2.
Evidence for Th Polarisation | Ref. | |
---|---|---|
Th1 | ||
Atherosclerosis | CD4+ T-cells dominate atherosclerotic plaques. Increase IFN-γ and IL-2, IL-12, IL-18. | [70] |
Rheumatoid arthritis | Increase in IFN-γ+CD4+ T-cells in peripheral blood and IFN-γ and TNF-α expression. Reduction in IL-6 and IL10 expression. |
[105] |
Type I diabetes | High IFN-γ expression drives persistent signal in pancreatic beta cells. | [106] |
Multiple sclerosis | IFN-γ-producing Th1 cells most frequent Th cell subset in the CNS. | [107] |
Parkinson’s | PD patients more Th1 cells and fewer Treg cells. CD4+ T-cells mediate brain inflammation. |
[108] [109] |
Th2 | ||
Asthma | Production of Th2 cytokines IL-4, IL-13, IL-5, increased production of IgE by B-cells. Genes that enhanced Th2 polarisation (IL17RB) and Th2 cytokine (IL-25) production were upregulated in asthma. |
[110] [111] |
Ulcerative colitis | Overexpression of Bcl2L12 by CD4+ T-cells upregulates Th2 responses and downregulates Th2 ell apoptosis. | [112] |
Chronic fatigue syndrome | Shift from Th1 to Th2 profile correlated with illness parameters including increase in IL-4 and reduced natural killer cell cytotoxicity. | [113] |